- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05454046
Food Intake Among Women and Men in Fertility Treatment (Food&Fertility)
July 7, 2026 updated by: Ulrik Schiøler Kesmodel, Aalborg University Hospital
Food & Fertility - Does Food Intake Affect Your Fertility?
Worldwide infertility is highly prevalent and lifestyle factors, such as food intake, could have an essential role in the success of a fertility treatment.
The literature is not consistent and adequate for recommendations to the increasing number of women and men of reproductive age who ask for lifestyle guidance.
Therefore, the aims of the Food & Fertility study will be to investigate the association between food intake and semen quality, pregnancy- and live birth rates in women and men undergoing assisted reproductive technology (ART) treatment.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The Food & Fertility study is a multicenter prospective cohort study which is planned to enroll a total of 4000 women and men undergoing fertility treatment between 2022 and 2028.
The data collection will take place at five Danish public and three private fertility clinics through a web-based food frequency questionnaire (FFQ).
Data on sperm quality and pregnancy- and live birth rates will be obtained from medical records and national registers.
Study Type
Observational
Enrollment (Estimated)
4000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ulrik S. Kesmodel, Professor
- Phone Number: (+45) 30206850
- Email: u.kesmodel@rn.dk
Study Contact Backup
- Name: Maria B. Borgstrøm
- Phone Number: (+45) 29299493
- Email: maria.borgstroem@regionh.dk
Study Locations
-
-
-
Aalborg, Denmark
- Recruiting
- Aalborg University Hospital
-
Contact:
- Ulrik Kesmodel
- Email: u.kesmodel@rn.dk
-
Aarhus, Denmark
- Recruiting
- Klinik Bay, Gynaecology and Fertility
-
Contact:
- Bjørn Bay
- Email: bb@maigaard.dk
-
Aarhus, Denmark
- Recruiting
- Maigaard Fertility Clinic
-
Contact:
- Kirsten Simonsen
- Email: ks@maigaard.dk
-
Copenhagen, Denmark
- Recruiting
- Copenhagen Fertility Center
-
Contact:
- Frederikke Lindenberg
- Email: frederikke@lindenberg.dk
-
Herlev, Denmark
- Recruiting
- Herlev Hospital Copenhagen
-
Contact:
- Maria Borgstrøm
- Email: maria.borgstroem@regionh.dk
-
Contact:
- Email: maria.borgstroem@regionh.dk
-
Horsens, Denmark
- Recruiting
- Regional Hospital Horsens
-
Contact:
- Peter Humaidan
- Email: peter.humaidan@midt.rm.dk
-
Odense, Denmark, 5000
- Recruiting
- Odense University Hospital
-
Skive, Denmark
- Recruiting
- Regional Hospital Skive
-
Contact:
- Kirstine Kirkegaard
- Email: kirstkrk@rm.dk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Women and men undergoing ART treatment or intrauterine insemination (IUI) at the fertility clinics at Aalborg University Hospital, Herlev University Hospital, Odense University Hospital, the Regional Hospitals in Horsens and Skive Copenhagen Fertility Center, Klinik Bay, Gynaecology and Fertility, and Maigaard Fertility Clinic in Aarhus will be invited to participate in the study (n=4000).
Description
Inclusion Criteria:
- Women and men undergoing fertility treatment: in vitro fertilization (IVF), intracytoplasmatic sperm injection (ICSI), frozen-thawed embryo transfer (FET) or intrauterine insemination (IUI).
- Availability of a semen sample analyzed 3 months before or after filling in the FFQ.
- Read and understands Danish.
Exclusion Criteria:
- Treatment with double donation (both semen and oocyte donation)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Women
|
Filling in an FFQ
|
|
Men
|
Filling in an FFQ
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Probability of live birth
Time Frame: From filling out the FFQ to birth (approximately 9-10months)
|
From filling out the FFQ to birth (approximately 9-10months)
|
|
Probability of pregnancy
Time Frame: From filling out the FFQ to end of treatment cycle (approximately 3 weeks)
|
From filling out the FFQ to end of treatment cycle (approximately 3 weeks)
|
|
Semen quality
Time Frame: +/- 3 months from filling out the FFQ
|
+/- 3 months from filling out the FFQ
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2022
Primary Completion (Estimated)
August 1, 2028
Study Completion (Estimated)
August 1, 2028
Study Registration Dates
First Submitted
July 8, 2022
First Submitted That Met QC Criteria
July 8, 2022
First Posted (Actual)
July 12, 2022
Study Record Updates
Last Update Posted (Actual)
July 8, 2026
Last Update Submitted That Met QC Criteria
July 7, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AGR-2019-731-9666
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.